Is THAR or HDV a better dividend investment in 2026?

THAR currently yields 57.64% with a 5% 5-year dividend growth rate. HDV yields 2.92% with 4.8% growth. The better choice depends on your goal: THAR offers higher current income.

What is the dividend yield difference between THAR and HDV?

THAR has a forward dividend yield of 57.64% ($2.00/share annually). HDV yields 2.92% ($3.96/share annually). The yield gap is 54.72 percentage points.

Home › Compare › THAR vs HDV

THAR vs HDV: Dividend Comparison 2026

THAR yields 57.64% · HDV yields 2.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 THAR wins by $555.5K in total portfolio value

INVESTMENT

TIME HORIZON10 years

THAR

● Live price

57.64%

Share price

$3.47

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$579.9K

Annual income

$131,396.64

Full THAR calculator →

HDV

iShares Core High Dividend ETF

● Live price

2.92%

Share price

$135.39

Annual div

$3.96

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$24.3K

Annual income

$352.73

Full HDV calculator →

Portfolio growth — THAR vs HDV

📍 THAR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	THAR	HDV
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, THAR + HDV cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

THAR pays

HDV pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

THAR

Annual income on $10K today (after 15% tax)

$4,899.14/yr

After 10yr DRIP, annual income (after tax)

$111,687.14/yr

HDV

Annual income on $10K today (after 15% tax)

$248.52/yr

After 10yr DRIP, annual income (after tax)

$299.82/yr

At 15% tax rate, THAR beats the other by $111,387.32/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of THAR + HDV for your $10,000?

THAR: 50%HDV: 50%

100% HDV50/50100% THAR

Portfolio after 10yr

$302.1K

Annual income

$65,874.68/yr

Blended yield

21.81%

📊

Analyst Conviction Gap

Where Wall Street is split right now

THAR

Analyst Ratings

Hold

Consensus: Hold

Altman Z

0.4

Piotroski

2/9

HDV

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

THAR buys

HDV buys

No recent congressional trades found for THAR or HDV in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTHARHDV

Forward yield	57.64% ✓	2.92%
Annual dividend / share	$2.00	$3.96 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$579.9K ✓	$24.3K
Annual income after 10y	$131,396.64 ✓	$352.73
Total dividends collected	$477.1K ✓	$3.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: THAR vs HDV ($10,000, DRIP)

Year	THAR Portfolio	THAR Income/yr	HDV Portfolio	HDV Income/yr	Gap
1← crossover	$16,464	$5,763.69	$11,002	$292.38	+$5.5K → THAR
2	$26,485	$8,868.37	$12,084	$300.36	+$14.4K → THAR
3	$41,671	$13,332.91	$13,250	$308.02	+$28.4K → THAR
4	$64,194	$19,605.90	$14,506	$315.35	+$49.7K → THAR
5	$96,915	$28,226.79	$15,858	$322.35	+$81.1K → THAR
6	$143,525	$39,826.39	$17,313	$329.04	+$126.2K → THAR
7	$208,694	$55,122.07	$18,878	$335.42	+$189.8K → THAR
8	$298,210	$74,907.23	$20,560	$341.49	+$277.6K → THAR
9	$419,119	$100,035.01	$22,367	$347.25	+$396.8K → THAR
10	$579,854	$131,396.64	$24,307	$352.73	+$555.5K → THAR

THAR vs HDV: Complete Analysis 2026

THAR — Stock

Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic diseases. The company's pre-clinical immuno-oncology pipeline includes TH104, a product candidate for the treatment of liver-related and other pruritogenic inflammatory conditions; TH3215 and TH0059 that are product candidates used to treat various solid tumors; and TH1940, which targets programmed cell death protein 1 (PD-1). It has a research collaboration and product license agreement with Minotaur Therapeutics, Inc. for the development of proprietary targeted biologics. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was incorporated in 2017 and is headquartered in Bridgewater, New Jersey.

Full THAR Calculator →

HDV — ETF

The iShares Core High Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full HDV Calculator →

📬

Get this THAR vs HDV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

THAR vs SCHD THAR vs JEPI THAR vs O THAR vs KO THAR vs MAIN THAR vs VYM THAR vs DVY THAR vs SPHD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.